Your browser doesn't support javascript.
loading
Designing Fluorescent Nuclear Permeable Peptidomimetics to Target Proliferating Cell Nuclear Antigen.
Horsfall, Aimee J; Chav, Theresa; Pederick, Jordan L; Kikhtyak, Zoya; Vandborg, Bethiney C; Kowalczyk, Wioleta; Scanlon, Denis B; Tilley, Wayne D; Hickey, Theresa E; Abell, Andrew D; Bruning, John B.
Afiliación
  • Horsfall AJ; Institute of Photonics and Advanced Sensing (IPAS), The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Chav T; School of Physical Sciences, The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Pederick JL; Australian Research Council Centre of Excellence for Nanoscale BioPhotonics (CNBP), Adelaide, South Australia 5005, Australia.
  • Kikhtyak Z; Institute of Photonics and Advanced Sensing (IPAS), The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Vandborg BC; School of Physical Sciences, The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Kowalczyk W; Australian Research Council Centre of Excellence for Nanoscale BioPhotonics (CNBP), Adelaide, South Australia 5005, Australia.
  • Scanlon DB; Institute of Photonics and Advanced Sensing (IPAS), The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Tilley WD; School of Biological Sciences, The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Hickey TE; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Abell AD; Institute of Photonics and Advanced Sensing (IPAS), The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Bruning JB; School of Biological Sciences, The University of Adelaide, Adelaide, South Australia 5005, Australia.
J Med Chem ; 66(15): 10354-10363, 2023 08 10.
Article en En | MEDLINE | ID: mdl-37489955
ABSTRACT
Human proliferating cell nuclear antigen (PCNA) is a critical mediator of DNA replication and repair, acting as a docking platform for replication proteins. Disrupting these interactions with a peptidomimetic agent presents as a promising avenue to limit proliferation of cancerous cells. Here, a p21-derived peptide was employed as a starting scaffold to design a modular peptidomimetic that interacts with PCNA and is cellular and nuclear permeable. Ultimately, a peptidomimetic was produced which met these criteria, consisting of a fluorescein tag and SV40 nuclear localization signal conjugated to the N-terminus of a p21 macrocycle derivative. Attachment of the fluorescein tag was found to directly affect cellular uptake of the peptidomimetic, with fluorescein being requisite for nuclear permeability. This work provides an important step forward in the development of PCNA targeting peptidomimetics for use as anti-cancer agents or as cancer diagnostics.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Peptidomiméticos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Peptidomiméticos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article